Form 4: CEL-SCI Corp Director Acquires Stock Options
SEC Form 4 Filing
Robert Eugene Watson, a director of CEL-SCI Corp, acquired 64,000 stock options on April 19, 2024.
Summary
- On April 19, 2024, Robert Eugene Watson, a director of CEL-SCI Corp, acquired 64,000 stock options.
- The options have an exercise price of $1.50.
- The options vest in three equal annual installments starting one year after the grant date.
- The options expire on April 18, 2034.
- Following the transaction, Watson directly owns 698,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing the acquisition of stock options by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors. It's common for directors to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 04/19/2024 | Date of transaction: Director acquired stock options |
| 04/19/2025 | First vesting date for the stock options |
| 04/18/2034 | Expiration date of the stock options |
| 04/23/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.